Unknown PHASE3 INTERVENTIONAL 4-arm NCT00546988

Multi Centre Trial of DSMM for Newly Diagnosed Multiple Myeloma up to 60 Years

Multizentrische Therapiestudie Des Multiplen Myeloms DSMM V Therapieoptimierungs-Studie Der Deutschen Studiengruppe Multiples Myelom für Patienten Bis 60 Jahre im Stadium II/III

Sponsor: University of Wuerzburg

Conditions Multiple Myeloma

Interventions allogeneic stem cell transplant

Updated 5 times since 2017 Last updated: Oct 17, 2007 Started: Oct 31, 2001 Completion: Jan 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Multiple Myeloma, this trial is ongoing. The trial is conducted by University of Wuerzburg and has accumulated 5 data snapshots since 2001. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE3
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE3

First recorded

Oct 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Wuerzburg

Data source: University of Wuerzburg

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Augsburg, Germany , Berlin, Germany , Erlangen, Germany , Frankfurt, Germany , Freiburg im Breisgau, Germany , Graz, Austria , Greifswald, Germany , Göttingen, Germany , Halle, Germany , Hamburg, Germany and 15 more locations